Cargando…

Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis

Molecular-based subclassifications of breast cancer are important for identifying treatment options and stratifying the prognosis in breast cancer. This study aimed to assess the prognosis relative to disease-free survival (DFS) and overall survival (OS) in patients with triple-negative breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulmeyer, Carla E., Fasching, Peter A., Häberle, Lothar, Meyer, Julia, Schneider, Michael, Wachter, David, Ruebner, Matthias, Pöschke, Patrik, Beckmann, Matthias W., Hartmann, Arndt, Erber, Ramona, Gass, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914743/ https://www.ncbi.nlm.nih.gov/pubmed/36766486 http://dx.doi.org/10.3390/diagnostics13030372

Ejemplares similares

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
por: Pöschke, Patrik, et al.
Publicado: (2023)

PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer
por: Erber, Ramona, et al.
Publicado: (2020)

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
por: Erber, Ramona, et al.
Publicado: (2020)

Mammographic density and prognosis in primary breast cancer patients
por: Heindl, Felix, et al.
Publicado: (2021)

HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
por: Wuerfel, Franziska M., et al.
Publicado: (2020)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
por: Gass, Paul, et al.
Publicado: (2018)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
por: Wachter, David L., et al.
Publicado: (2014)

Improving the Quality of Care for Cancer Patients through Oncological Second Opinions in a Comprehensive Cancer Center: Feasibility of Patient-Initiated Second Opinions through a Health-Insurance Service Point
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer
por: Ranjan, Raphela A., et al.
Publicado: (2023)

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
por: Hein, Alexander, et al.
Publicado: (2014)

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
por: Gass, Paul, et al.
Publicado: (2018)

DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2016)

Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
por: Gebrekidan, Medhanie Tesfay, et al.
Publicado: (2018)

Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
por: Burghaus, Stefanie, et al.
Publicado: (2015)

Relationship of CK8/18 expression pattern to breast cancer immunohistochemical subtyping in Egyptian patients
por: Aiad, Hayam A, et al.
Publicado: (2014)

Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma
por: Erber, Ramona, et al.
Publicado: (2021)

Feasibility and Acceptance of Self-Guided Mobile Ultrasound among Pregnant Women in Routine Prenatal Care
por: Pontones, Constanza A., et al.
Publicado: (2023)

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
por: Huebner, Hanna, et al.
Publicado: (2018)

Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
por: Wunderle, Marius, et al.
Publicado: (2018)

An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy
por: Kaur, Amanpreet, et al.
Publicado: (2022)

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis
por: Sikic, Danijel, et al.
Publicado: (2017)

CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective
por: Akhtar, Mohammed, et al.
Publicado: (2020)

Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial Lesions
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Standardized Procedures for Patients with Dysplasia and Other Diseases of the Cervix, Vulva, and Vagina at a Certified Dysplasia Unit Prior to the Introduction of the Organized Cervical Cancer Screening Program
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2015)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2016)

Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer
por: Yun, Sung Pil, et al.
Publicado: (2015)

Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants
por: Popp, Bernt, et al.
Publicado: (2020)

Immunohistochemical evaluation of CD117 in mast cell of aggressive periodontitis
por: Mazreah, Siavash Azizi, et al.
Publicado: (2020)

Immunohistochemical study of CD117 in various cutaneous melanocytic lesions
por: Radu, Antonia, et al.
Publicado: (2021)

Low-Risk Women with Suspicious Microcalcifications in Mammography—Can an Additional Breast MRI Reduce the Biopsy Rate?
por: Pöschke, Patrik, et al.
Publicado: (2023)

Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting
por: Erber, Ramona, et al.
Publicado: (2022)

Prominent entrapment of respiratory epithelium in primary and metastatic intrapulmonary non-epithelial neoplasms: a frequent morphological pattern closely mimicking adenofibroma and other biphasic pulmonary lesions
por: Erber, Ramona, et al.
Publicado: (2020)

Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment
por: Erber, Ramona, et al.
Publicado: (2021)

RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
por: Wunderle, Marius, et al.
Publicado: (2020)

Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study
por: Stuebs, Frederik A., et al.
Publicado: (2023)

The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines
por: Subik, Kristina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1i121ijpourpdemjls43ufhds6